FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101148 [Registered on: 14/01/2026] Trial Registered Prospectively
Last Modified On: 14/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Testing a Walking Balance Scale to Check Walking Ability and Balance in Stroke Patients with Weakness 
Scientific Title of Study   Hindi Translation, Validation and Reliability Testing of the Dynamic Gait Index in Stroke Patients with residual weakness 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  SUBHASISH CHATTERJEE 
Designation  Associate professor 
Affiliation  MAHARISHI MARKANDESHWAR INSTITUTE OF PHYSIOTHERAPY AND REHABILITATION 
Address  Room number 6 NEURO OPD MAHARISHI MARKANDESHWAR INSTITUTE OF PHYSIOTHERAPY AND REHABILITATION, MAHARISHI MARKANDESHWAR (DEEMED TO BE UNIVERSITY), MULLANA-AMBALA, HARYANA

Ambala
HARYANA
133203
India 
Phone  8708660994  
Fax    
Email  subhasishphysio@mmumullana.org  
 
Details of Contact Person
Scientific Query
 
Name  ANMOL 
Designation  Postgraduate Student 
Affiliation  MAHARISHI MARKANDESHWAR INSTITUTE OF PHYSIOTHERAPY AND REHABILITATION 
Address  Room number 6 General OPD MAHARISHI MARKANDESHWAR INSTITUTE OF PHYSIOTHERAPY AND REHABILITATION, MAHARISHI MARKANDESHWAR (DEEMED TO BE UNIVERSITY), MULLANA-AMBALA, HARYANA

Ambala
HARYANA
133203
India 
Phone  7707831136  
Fax    
Email  anmoljgl@gmail.com  
 
Details of Contact Person
Public Query
 
Name  ANMOL 
Designation  Postgraduate Student 
Affiliation  MAHARISHI MARKANDESHWAR INSTITUTE OF PHYSIOTHERAPY AND REHABILITATION 
Address  Room number 6 General OPD MAHARISHI MARKANDESHWAR INSTITUTE OF PHYSIOTHERAPY AND REHABILITATION, MAHARISHI MARKANDESHWAR (DEEMED TO BE UNIVERSITY), MULLANA-AMBALA, HARYANA

Ambala
HARYANA
133203
India 
Phone  7707831136  
Fax    
Email  anmoljgl@gmail.com  
 
Source of Monetary or Material Support  
MAHARISHI MARKANDESHWAR INSTITUTE OF PHYSIOTHERAPY AND REHABILITATION, MAHARISHI MARKANDESHWAR (DEEMED TO BE UNIVERSITY), MULLANA-AMBALA, HARYANA,133203 
 
Primary Sponsor  
Name  Anmol 
Address  MAHARISHI MARKANDESHWAR INSTITUTE OF PHYSIOTHERAPY AND REHABILITATION, MAHARISHI MARKANDESHWAR (DEEMED TO BE UNIVERSITY), MULLANA-AMBALA, HARYANA,133203 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anmol  MMIMSR Maharishi Markandeshwar Institute of Medical Sciences and Research  Room number. 6 Neuro OPD Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation, Maharishi Markandeshwar Deemed To Be University, Mullana, Ambala, Haryana, 133203
Ambala
HARYANA 
7707831136

anmoljgl@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee of Maharishi Markandeshwar Institute Of Medical Sciences And Research, Maharishi Markandeshwar Deemed To Be University  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I998||Other disorder of circulatory system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  45.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Individuals with a basic understanding of Hindi and no significant health impairments.
Both males and females will be included.
 
 
ExclusionCriteria 
Details  Participants with cognitive impairments.
Un-cooperative patients.
Non-native Hindi speakers.
Psychiatric disorders. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Dynamic Gait Index (DGI)  Measure at the time of baseline  
 
Secondary Outcome     
Target Sample Size   Total Sample Size="51"
Sample Size from India="51" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Background: The Dynamic Gait Index (DGI) is a assessment tool is used to evaluate gait stability and predict the risk of fall among older adults and the individuals having balance issue. The DGI comprises eight functional tasks that assess the aspects of gait and balance during dynamic movements. DGI includes walking at a normal speed , Quickly walking, walking while changing direction, and walking while performing a another task, such as head turns or stepping over obstacles. Purpose: The purpose of this study is to translate into the Hindi version of the Dynamic Gait Index (DGI) and to evaluate its validity and reliability. Study design: A cross-sectional study. Methods: The study method includes the translation of the Dynamic Gait Index (DGI) in the Hindi language from English by 2 translators i.e. T1 and T2 from medical and non-medical backgrounds respectively. The recording observer then takes a seat to create a T12 version of the translated questionnaire. The reverse translation from the T12 form to the previous form is now being done. Then, an expert panel analyses all the stages and all of the items that the translated form is free of errors, allowing it to be field tested. Evaluation of the content’s validity is done. The pre-final form is then fully tested on patients, and the scale’s validity is reported. Finally, the translated version will be analyzed by the ethics committee. 
Close